Sign In
Buy MEDP
$458.69
+7.88 (+1.75%)
At Close: Jun 04, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medpace Holdings, Inc. - MEDP
11:00am, Friday, 25'th Oct 2024
NEW YORK , Oct. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). Such investors are advis
MEDP Investors Have Opportunity to Join Medpace Holdings, Inc. Fraud Investigation with the Schall Law Firm
10:51am, Friday, 25'th Oct 2024
LOS ANGELES , Oct. 25, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace Holdings, I
RADNOR, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behal
MEDP Investors Have Opportunity to Join Medpace Holdings, Inc. Fraud Investigation with the Schall Law Firm
05:50pm, Wednesday, 23'rd Oct 2024
LOS ANGELES--(BUSINESS WIRE)--MEDP Investors Have Opportunity to Join Medpace Holdings, Inc. Fraud Investigation with the Schall Law Firm.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medpace Holdings, Inc. - MEDP
04:30pm, Wednesday, 23'rd Oct 2024
/ ACCESSWIRE / October 23, 2024 / NEW YORK, NY / ACCESSWIRE / October 23, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or the "Company") (NA
RADNOR, Pa. , Oct. 23, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf
RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf
Medpace Holdings, Inc. (MEDP) Q3 2024 Earnings Call Transcript
05:33pm, Tuesday, 22'nd Oct 2024
Medpace Holdings, Inc. (NASDAQ:MEDP ) Q3 2024 Earnings Conference Call October 22, 2024 9:00 AM ET Company Participants Lauren Morris - Director, Investor Relations August Troendle - Chief Executive O
Why Is Medpace Stock Diving On Tuesday?
12:07pm, Tuesday, 22'nd Oct 2024
Medpace Holdings, Inc. MEDP shares are trading lower on Tuesday after reporting its third-quarter financial results yesterday.
Medpace Stock Drops. Biotech's Doldrums Are to Blame.
10:09am, Tuesday, 22'nd Oct 2024
The drug-testing company saw higher-than-normal levels of cancellations in the third quarter.
Medpace (MEDP) Tops Q3 Earnings Estimates
06:26pm, Monday, 21'st Oct 2024
Medpace (MEDP) came out with quarterly earnings of $3.01 per share, beating the Zacks Consensus Estimate of $2.77 per share. This compares to earnings of $2.22 per share a year ago.
Medpace Holdings, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights – MEDP
04:45pm, Monday, 21'st Oct 2024
NEW YORK, NY / ACCESSWIRE / October 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace Holdings, Inc.") (NASDAQ:MEDP) concerning
Medpace Holdings, Inc. Reports Third Quarter 2024 Results
04:15pm, Monday, 21'st Oct 2024
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Result
NEW YORK, NY / ACCESSWIRE / October 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Medpace Holdings, Inc. ("Medpace Holdings, Inc.") (NASDAQ:MEDP) concerning
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medpace Holdings, Inc. - MEDP
12:00pm, Saturday, 19'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ:MEDP). Such investors are adv
